Perifosine overcome MEK inhibitor resistance in PIK3CA-mutated colorectal carcinoma

被引：0
|
作者：
Yamamoto, Yuuta [1 ]
Tsubaki, Masanobu [1 ]
Takeda, Tomoya [1 ]
Matsuda, Takuya [1 ]
Kimura, Akihiro [1 ]
Nishida, Shozo [1 ]
机构：
[1] Kindai Univ, Dept Pharmacotherapy, Fac Pharm, Higashiosaka, Osaka, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P16-1-5
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [31] Einsatz von Alpelisib beim fortgeschrittenen PIK3CA-mutierten MammakarzinomUse of alpelisib for PIK3CA-mutated advanced breast cancer
    Wolfram Malter
    Hakan Alakus
    Peter Mallmann
    Christiane Bruns
    Der Onkologe, 2019, 25 (8): : 724 - 725
  • [32] Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma
    Baba, Yuh
    Maeda, Toyonobu
    Suzuki, Atsuko
    Takada, Satoshi
    Fujii, Masato
    Kato, Yasumasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [33] Alpelisib for PIK3CA-mutated advanced gynecological cancers: first clues of clinical activity
    Passarelli, Anna
    Carbone, Maria Vittoria
    Pignata, Sandro
    Mazzeo, Roberta
    Lorusso, Domenica
    Scambia, Giovanni
    Canova, Stefania
    Di Palma, Teresa
    Tasca, Giulia
    Mantiero, Mara
    Naglieri, Emanuele
    Andreetta, Claudia
    Rauso, Martina
    Brunetti, Anna Elisabetta
    Laera, Letizia
    Abeni, Chiara
    Scandurra, Giuseppa
    Gambaro, Anna Rita
    Pastore, Alessia
    Bengala, Carmelo
    Gunnellini, Marco
    Farolfi, Alberto
    Spinello, Maurizio
    Bartoletti, Michele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A277 - A278
  • [34] FDA Approves Inavolisib Combo for PIK3CA-Mutated, HR plus Breast Cancer
    Zhang, Jinwei
    CURRENT MEDICINAL CHEMISTRY, 2025,
  • [35] Outcome and mutational landscape of patients with PIK3CA-mutated metastatic breast cancer (mBC)
    Mosele, M. F.
    Lusque, A.
    Dien, A. Tran
    Droin, N.
    Le Tourneau, C.
    Lacroix, L.
    Bieche, I.
    Massard, C.
    Bertucci, F.
    Andre, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [36] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
    Andre, Fabrice
    Ciruelos, Eva
    Rubovszky, Gabor
    Campone, Mario
    Loibl, Sibylle
    Rugo, Hope S.
    Iwata, Hiroji
    Conte, Pierfranco
    Mayer, Ingrid A.
    Kaufman, Bella
    Yamashita, Toshinari
    Lu, Yen-Shen
    Inoue, Kenichi
    Takahashi, Masato
    Papai, Zsuzsanna
    Longin, Anne-Sophie
    Mills, David
    Wilke, Celine
    Hirawat, Samit
    Juric, Dejan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20): : 1929 - 1940
  • [37] Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
    Passarelli, Anna
    Carbone, Vittoria
    Pignata, Sandro
    Mazzeo, Roberta
    Lorusso, Domenica
    Scambia, Giovanni
    Canova, Stefania
    Di Palma, Teresa
    Tasca, Giulia
    Mantiero, Mara
    Naglieri, Emanuele
    Andreetta, Claudia
    Rauso, Martina
    Brunetti, Anna Elisabetta
    Laera, Letizia
    Abeni, Chiara
    Scandurra, Giuseppa
    Gambaro, Anna Rita
    Pastore, Alessia
    Bengala, Carmelo
    Gunnellini, Marco
    Farolfi, Alberto
    Spinello, Maurizio
    Bartoletti, Michele
    GYNECOLOGIC ONCOLOGY, 2024, 183 : 61 - 67
  • [38] Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
    Yeom, Jiah
    Cho, Yoonju
    Ahn, Seoungyob
    Jeung, Soyoung
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [39] PIK3CA and PIK3CB expression and relationship with multidrug resistance in colorectal carcinoma
    Wen, Feifei
    He, Shuang
    Sun, Chenbo
    Li, Tangyue
    Wu, Shuhua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (11): : 8295 - 8303
  • [40] Immune cell infiltration and drug sensitivity in PIK3CA-mutated esophageal squamous cell carcinoma: A TCGA database analysis
    He, Shuo
    Liu, Qing
    Luo, Shujuan
    Cai, Bangwu
    Chen, Jiao
    Peng, Tianyuan
    Wang, Wei
    Liu, Tao
    Lu, Xiaomei
    Zheng, Shutao
    HUMAN IMMUNOLOGY, 2024, 85 (06)
12345